Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Injury ; 53(3): 1202-1208, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34602245

RESUMO

INTRODUCTION: The purpose of this study was to investigate neurological disorder as a risk factor for dislocation following arthroplasty for acute hip fractures. We also analysed medical and surgical adverse events (AE), readmission, reoperation, revision, and mortality as secondary outcomes. METHODS: A longitudinal cohort study using prospectively collected and aggregated data from the Swedish Hip Arthroplasty Register (SHAR) and the Swedish national patient register. All patients presenting with an acute hip fracture and treated with an arthroplasty in the period from 2005 to 2014 from the SHAR were identified. Patients in receipt of bilateral arthroplasties were excluded. Patients with a relevant pre-existing and diagnosed neurological disorder, as defined by ICD-10 codes, were identified (n = 9,702). All other cases (n = 29,411) were available for logistic regression propensity score matching. Patients were 1:1 matched on age, sex, Charlson comorbidity index, total versus hemiarthroplasty, head size, surgical approach, and year of surgery. Dislocations, adverse events, readmission, reoperation, revision, and mortality were studied using Kaplan-Meier analysis and Cox regression. RESULTS: The risk of dislocations was higher for patients with neurological disorder (HR=1.19, CI 1.03- 1.39, p<0.05). Neurological disorder was associated with increased risk of encountering an adverse event (p<0.001 at 90-days); these patients were at higher risk of dying (HR=1.51, CI 1.47-1.56, p<0.001) however they were less likely to be readmitted (HR=0.73, CI 0.70- 0.76, p<0.001). No excess risks of reoperation (HR=1.02, CI 0.90-1.17; p = 0.73) or revision (HR=1.00, CI 0.86-1.17; p = 0.99) were identified in the study group. DISCUSSION: Compared to matched controls, individuals with a preoperatively identified neurological diagnosis had higher rates of mortality, dislocations, and adverse events, but this cohort was not at increased risk of reoperation or revision. This study highlights an area of focus for future research to improve the long-term outcomes in patients with neurological disease undergoing arthroplasty for an acute hip fracture.


Assuntos
Artroplastia de Quadril , Fraturas do Quadril , Prótese de Quadril , Doenças do Sistema Nervoso , Artroplastia de Quadril/efeitos adversos , Fraturas do Quadril/epidemiologia , Fraturas do Quadril/etiologia , Fraturas do Quadril/cirurgia , Humanos , Estudos Longitudinais , Doenças do Sistema Nervoso/epidemiologia , Doenças do Sistema Nervoso/etiologia , Sistema de Registros , Reoperação , Fatores de Risco , Suécia/epidemiologia
2.
Clin Orthop Relat Res ; 477(6): 1347-1355, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-31136433

RESUMO

BACKGROUND: Neurological conditions such as Parkinson's disease are commonly accepted as a risk factor for an increased likelihood of undergoing revision surgery or death after THA. However, the available evidence for an association between Parkinson's disease and serious complications or poorer patient-reported outcomes after THA is limited and contradictory. QUESTIONS/PURPOSES: (1) Do patients with a preoperative diagnosis of Parkinson's disease have an increased risk of death after elective THA compared with a matched control group of patients? (2) After matching for patient- and surgery-related factors, do revision rates differ between the patients with Parkinson's disease and the matched control group? (3) Are there any differences in patient-reported outcome measures for patients with Parkinson's disease compared with the matched control group? METHODS: Data were derived from a merged database with information from the Swedish Hip Arthroplasty Register and administrative health databases. We identified all patients with Parkinson's disease who underwent THA for primary osteoarthritis between January 1, 1999 and December 31, 2012 (n = 490 after exclusion criteria applied). A control group was generated through exact one-to-one matching for age, sex, Charlson comorbidity index, surgical approach, and fixation method. Risk of death and revision were compared between the groups using Kaplan-Meier and log-rank testing. Patient-reported outcome measures (PROMs), routinely recorded as EQ-5D, EQ VAS, and pain VAS, were measured at the preoperative visit and at 1-year postoperatively; mean absolute values for PROM scores and change in scores over time were compared between the two groups. RESULTS: The risk of death did not differ at 90 days (control group risk = 0.61%; 95% CI = 0.00-1.3; Parkinson's disease group risk = 0.62%; 95% CI = 0.00-1.31; p = 0.998) or 1 year (control group = 2.11%; 95% CI = 0.81-3.39; Parkinson's disease group = 2.56%, 95% CI = 1.12-3.97; p = 0.670). At 9 years, the risk of death was increased for patients with Parkinson's disease (control group = 28.05%; 95% CI = 22.29-33.38; Parkinson's disease group = 54.35%; 95% CI = 46.72-60.88; p < 0.001). The risk of revision did not differ at 90 days (control group = 0.41%; 95% CI = 0.00-0.98; Parkinson's disease group = 1.03%; 95% CI = 0.13-1.92; p = 0.256). At 1 year, the risk of revision was higher for patients with Parkinson's disease (control group = 0.41%; 95% CI = 0.00-0.98; Parkinson's disease group = 2.10%; 95% CIs = 0.80-3.38; p = 0.021). This difference was more pronounced at 9 years (control group = 1.75%; 95% CI = 0.11-3.36; Parkinson's disease group = 5.44%; 95% CI = 2.89-7.91; p = 0.001) when using the Kaplan-Meier method. There was no difference between the control and Parkinson's disease groups for level of pain relief at 1 year postoperatively (mean reduction in pain VAS score for control group = 48.85, SD = 20.46; Parkinson's disease group = 47.18, SD = 23.96; p = 0.510). Mean change in scores for quality of life and overall health from preoperative measures to 1 year postoperatively were smaller for patients in the Parkinson's disease group compared with controls (mean change in EQ-5D scores for control group = 0.42, SD = 0.32; Parkinson's disease group = 0.30, SD = 0.37; p 0.003; mean change in EQ VAS scores for control group = 20.94, SD = 23.63; Parkinson's disease = 15.04, SD = 23.00; p = 0.027). CONCLUSIONS: Parkinson's disease is associated with an increased revision risk but not with short-term mortality rates relevant to assessing risk versus benefit before undergoing THR. The traditional reluctance to perform THR in patients with Parkinson's disease may be too conservative given that the higher long-term risk of death is more likely due to the progressive neurological disorder and not THR itself, and patients with Parkinson's disease report comparable outcomes to controls. Further research on outcomes in THR for patients with other neurological conditions is needed to better address the broader assumptions underlying this traditional teaching.Level of Evidence Level III, therapeutic study.


Assuntos
Artroplastia de Quadril/mortalidade , Osteoartrite do Quadril/cirurgia , Doença de Parkinson/complicações , Complicações Pós-Operatórias/mortalidade , Reoperação/estatística & dados numéricos , Idoso , Estudos de Casos e Controles , Feminino , Humanos , Estimativa de Kaplan-Meier , Masculino , Medição da Dor , Medidas de Resultados Relatados pelo Paciente , Sistema de Registros , Estudos Retrospectivos , Risco , Suécia/epidemiologia
3.
Neurodegener Dis Manag ; 5(6): 505-10, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26619032

RESUMO

AIMS: To measure current and comparative frequencies of use of the General Practitioner Assessment of Cognition (GPCOG) scale in consecutive primary care referrals to a dedicated secondary care memory clinic. METHODS: Over 6 months (January-June 2015), referral letters from primary care (n = 121) were examined for mention of GPCOG use. RESULTS: The proportion of patients administered any cognitive screening instrument before referral was 41.3%, with 11.6% administered the GPCOG, a significant increase compared with prior cohorts. However, GPCOG was incorrectly used or documented in 29% of cases. CONCLUSION: GPCOG use is increasing in primary care settings, but training in its correct use and scoring may be required to ensure that its administration makes meaningful information available.


Assuntos
Transtornos Cognitivos/diagnóstico , Demência/diagnóstico , Entrevista Psicológica/métodos , Testes Neuropsicológicos , Atenção Primária à Saúde/métodos , Atenção Secundária à Saúde/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Cognição , Estudos de Coortes , Feminino , Clínicos Gerais , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem
4.
PLoS One ; 10(6): e0127848, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26083640

RESUMO

The media have a key role in communicating advances in medicine to the general public, yet the accuracy of medical journalism is an under-researched area. This project adapted an established monitoring instrument to analyse all identified news reports (n = 312) on a single medical research paper: a meta-analysis published in the British Journal of Cancer which showed a modest link between processed meat consumption and pancreatic cancer. Our most significant finding was that three sources (the journal press release, a story on the BBC News website and a story appearing on the 'NHS Choices' website) appeared to account for the content of over 85% of the news stories which covered the meta analysis, with many of them being verbatim or moderately edited copies and most not citing their source. The quality of these 3 primary sources varied from excellent (NHS Choices, 10 of 11 criteria addressed) to weak (journal press release, 5 of 11 criteria addressed), and this variance was reflected in the accuracy of stories derived from them. Some of the methods used in the original meta-analysis, and a proposed mechanistic explanation for the findings, were challenged in a subsequent commentary also published in the British Journal of Cancer, but this discourse was poorly reflected in the media coverage of the story.


Assuntos
Disseminação de Informação/ética , Meios de Comunicação de Massa/ética , Neoplasias Pancreáticas/epidemiologia , Viés , Humanos , Metanálise como Assunto , Neoplasias Pancreáticas/etiologia , Neoplasias Pancreáticas/patologia , Carne Vermelha/efeitos adversos , Projetos de Pesquisa/estatística & dados numéricos
5.
Cognition ; 134: 39-49, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25460377

RESUMO

Sequential foreperiod effects in temporal preparation are typically asymmetric such that a previous experience of preparation has a strong impact on participants' responses to a forthcoming target stimulus presented at the current short rather than at the current long foreperiod. The trace-conditioning model explains this asymmetry by an automatic process of trace-conditioning, which is sufficient and independent from a strategic process of conditional probability monitoring considered by the dual-process model. The present study contrasted trace-conditioning and dual-process models in three experiments that employed a non-aging distribution to keep conditional probability of target occurrence constant across foreperiod durations. In Experiment 1 (no catch trials), the typical pattern of asymmetric sequential effects was replicated, whereas in Experiments 2 and 3 (25% and 50% of catch trials, respectively) the results showed shorter RTs when previous and current foreperiods were repeated rather than alternated for both current short and long foreperiods. These results are discussed in relation to the two most influential models of sequential effects and to a novel account based on repetition priming.


Assuntos
Modelos Psicológicos , Desempenho Psicomotor/fisiologia , Priming de Repetição/fisiologia , Adulto , Feminino , Humanos , Masculino , Fatores de Tempo , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA